Renal Denervation: Patient Selection and When to Refer

The US FDA approved Renal Denervation for hypertension treatment in November 2023. Regardless of the methodology used to denervate, most but not all people had a clinically significant reduction in blood pressure in the months following the procedure. In this review we summarize the current data inf...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2025-10, Vol.252, p.88-92
Main Authors: Voora, Raven A., Bloch, Michael J., Fisher, Naomi DL
Format: Article
Language:English
Subjects:
Antihypertensives
Blood pressure
Blood Pressure - physiology
Catheters
Clinical trials
Denervation
Humans
Hypertension
Hypertension - physiopathology
Hypertension - surgery
Kidney - innervation
Kidney diseases
Older people
patient referral
Patient Selection
Patients
Referral and Consultation
renal denervation
Sympathectomy - methods
Ultrasonic imaging
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!